Market Cap

Baotou Dongbao Bio-Tech Co.,Ltd Market Capitalization:

CN¥3.67 Billion

CNY as of Jan. 1, 2024

US$516.9 Million

business Baotou Dongbao Bio-Tech Co.,Ltd Company Profile

Baotou Dongbao Bio-Tech Co.,Ltd Main Stock Listing

SZSE: 300239

Market Capitalization History of Baotou Dongbao Bio-Tech Co.,Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Baotou Dongbao Bio-Tech Co.,Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥3.67 B -14.50%
Jan. 1, 2023 CN¥4.30 B 21.83%
Jan. 1, 2022 CN¥3.53 B 22.11%
Jan. 1, 2021 CN¥2.89 B -9.87%
Jan. 1, 2020 CN¥3.21 B 49.17%
Jan. 1, 2019 CN¥2.15 B -34.90%
Jan. 1, 2018 CN¥3.30 B -33.13%
Jan. 1, 2017 CN¥4.94 B 41.49%
Jan. 1, 2016 CN¥3.49 B -2.75%
Jan. 1, 2015 CN¥3.59 B -2.91%
Jan. 1, 2014 CN¥3.69 B 11.69%
Jan. 1, 2013 CN¥3.31 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Baotou Dongbao Bio-Tech Co.,Ltd Categories

China languages Healthcare languages Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Stocks & Indices

Baotou Dongbao Bio-Tech Co.,Ltd has the following listings and related stock indices.


Stock: SZSE: 300239

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.